An Open Label Clinical Trial to Evaluate the Efficacy of Vamana Karma in the Management of Urdwaga Amalpitta

Neetu Chauhan; Ashish Mehta

doi:10.21760/jaims.10.5.7

Neetu Chauhan Post Graduate Scholar, PG Department of Panchakarma, Institute for Ayurved Studies and Research, Shri Krishna Ayush University, Kurukshetra, Haryana, India.
Ashish Mehta Professor & Head, PG Department of Panchakarma, Institute for Ayurved Studies and Research, Shri Krishna Ayush University, Kurukshetra, Haryana, India.

DOI: https://doi.org/10.21760/jaims.10.5.7

Keywords: Annavahasrotas, Aahar-Vihar, Mandagni, Urdhwaga Amlapitta, Vamana, Gastritis, hyperacidity

Abstract

Background: Amlapitta is one of the most common & familiar disease of Annavaha Srotas in present era described in various classical Ayurvedic text. The primary cause of Amlapitta is Agnidushti due to Pitta Dosha vitiation, often triggered by faulty dietary habits, stress, and sedentary lifestyle. Traditional management of Amlapitta primarily involves Shodhana along with the Shamana Chikitsa Shodhana Chikitsa (purificatory therapy) is considered more effective for long-term relief and prevention of recurrence. Among the Shodhana therapies, Vaman Karma (therapeutic emesis) is the prime treatment for Kapha and Pitta vitiated disorders. Objective: To evaluate the efficacy of Vamana Karma in the management of Urdhwaga Amlapitta. Methodology: The study was a single-arm open-label clinical trial. A total of 30 patients with cardinal symptoms of Urdhwaga Amlapitta who meet the Vaman Karma criteria, aged 25-50 years of either sex, willing to participate in the study was picked for a 15-day period. Result: Change will be noted in the subjective parameter. Conclusion: Vaman Karma will reduce the symptoms of Urdhwaga-Amlapitta.

Downloads

Download data is not yet available.

References

Shastri AD. Sushruta Samhita of Maharsi Sushruta. Varanasi: Chaukhamba Sanskrit Sansthan; 2017. Vol. I. Sutrasthana, Ch. 15, Ver. 38.

Shastri AD. Sushruta Samhita of Maharsi Sushruta. Varanasi: Chaukhamba Sanskrit Sansthan; 2017. Vol. I. Sutrasthana, Ch. 21, Ver. 3.

Gupta AD. Astanga Hridayam of Vagbhata, edited with Vidyotini. Varanasi: Chaukhamba Prakashan; 2016. Sutrasthana, Ch. 2, Ver. 1.

Gupta AD. Astanga Hridayam of Vagbhata, edited with Vidyotini. Varanasi: Chaukhamba Prakashan; 2016. Sutrasthana, Ch. 3, Ver. 41.

Shastri K, Chaturvedi GN. Charaka Samhita of Agnivesh, edited with Vidyotini. Varanasi: Chaukhamba Bharti Academy; 2016. Vol. I. Vimana Sthana, Ch. 1, Ver. 29.

Shastri K, Chaturvedi GN. Charaka Samhita of Agnivesh, edited with Vidyotini. Varanasi: Chaukhamba Bharti Academy; 2016. Vol. I. Chikitsa Sthana, Ch. 15, Ver. 47.

Upadhyay Y. Madhava Nidana, Madhukosha Tika. Varanasi: Chaukhamba Sanskrit Publication; 2008. Part 2, Uttaradh, Ch. 51, Ver. 3-4.

Upadhyay Y. Madhava Nidana, Madhukosha Tika. Varanasi: Chaukhamba Sanskrit Publication; 2008. Part 2, Uttaradh, Ch. 51, Ver. 8-12.

Shastri K, Chaturvedi GN. Charaka Samhita of Agnivesh, edited with Vidyotini. Varanasi: Chaukhamba Bharti Academy; 2016. Vol. I. Chikitsa Sthana, Ch. 15, Ver. 42.

Shastri K, Chaturvedi GN. Charaka Samhita of Agnivesh, edited with Vidyotini. Varanasi: Chaukhamba Bharti Academy; 2016. Vol. I. Vimana Sthana, Ch. 1, Ver. 29.

Shastri AD. Sushruta Samhita of Maharsi Sushruta. Varanasi: Chaukhamba Sanskrit Sansthan; 2017. Vol. I. Sutrasthana, Ch. 21, Ver. 11.

Upadhyay Y. Madhava Nidana, Madhukosha Tika. Varanasi: Chaukhamba Sanskrit Publication; 2008. Part 2, Uttaradh, Ch. 51, Ver. 2. p. 338.

AYUSH Ministry [Internet]. Available from: https://namstp.ayush.gov.in/#/Ayurveda.

Baragi UC, Vyas MK. Clinical evaluation of the efficacy of Dashanga Kwatha Ghana Vati in the management of Urdhwaga Amlapitta (Non-ulcer dyspepsia). Ayu. 2012 Apr;33(2):219-23. doi:10.4103/0974-8520.105241. PMID: 23559793; PMCID: PMC3611627.

Wilson N, MJ P, Dr M. Conceptual understanding of Amlapitta (Gastritis). Int J Ayurveda Pharma Res. 2018;6(2). Available from: https://ijapr.in/index.php/ijapr/article/view/858.

Rout D, Panda PK, Nayak U, Biswal AK. A conceptual review of Amlapitta W.S.R to gastro-esophageal reflux disease. IRJAY. 2022;5(6):139-44.

Baragi PC, Baragi UC. A critical review of disease Amlapitta (Gastritis). J Ayurveda Integr Med Sci [Internet]. 2017 Feb 28 [cited 2025 Jun 16];2(1):167-79.

Bhatia SJ, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019 Oct;38(5):411-40. doi:10.1007/s12664-019-00979-y. Epub 2019 Dec 5. PMID: 31802441.

Shah N, Gossman W. Omeprazole. [Updated 2023 Feb 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539786/.

Maideen NMP. Adverse effects associated with long-term use of proton pump inhibitors. Chonnam Med J. 2023 May;59(2):115-27. doi:10.4068/cmj.2023.59.2.115. PMID: 37303818; PMCID: PMC10248387.

Shastri K, Chaturvedi GN. Charaka Samhita of Agnivesh, edited with Vidyotini. Varanasi: Chaukhamba Bharti Academy; 2016. Vol. I. Sutrasthana, Ch. 16, Ver. 20. p. 279.